IPS TMS for Patients with PTSD
Recruiting
18-60 years
All
Phase
1
120 participants needed
1 Location
Brief description of study
This study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). We will demonstrate that IPS cTBS results in significant target engagement in the form of reduction in anxiety-potentiated startle (APS) compared to sham cTBS and will identify the ideal dose of cTBS.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: PTSD
-
Age: Between 18 Years - 60 Years
-
Gender: All
Male or Female, Age 18-60, Diagnosed with PTSD, right-handed, no metal implants, not pregnant, no history of seizures/seizure disorders, ability to read and write in English
Updated on
01 Aug 2024.
Study ID: 849571
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
